Trials / Available
AvailableNCT03786900
Fecal Microbiota Transplantation (FMT): PRIM-DJ2727
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Herbert DuPont, MD · Academic / Other
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
The Fecal Microbiota Transplantation (FMT) product PRIM-DJ2727 is prepared from human stool from a healthy, screened donor. Requestors will contact the study team about the product (PRIM-DJ2727) by email, visit, or phone call. A screening list for donors will be provided to make sure that the list fits the requestor's requirements. A basic fee will be requested to recover the cost of making the product. After an agreement is made, a contract will be signed between the 2 parties. A week before the treatment, requestors will contact the study team for possible FMT product delivery. Delivery method will be confirmed for delivery by personnel (within 10 minutes driving distance) or by using FedEx services. Each delivered product will have an approved delivery form signed and dated by both the person who prepared the delivery and the person who received the package.
Conditions
- Recurrent Clostridium Difficile Infection
- Multidrug-resistant Klebsiella Pneumoniae Urinary Tract Infection
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fecal Microbiota Transplantation (FMT) product PRIM-DJ2727 |
Timeline
- First posted
- 2018-12-26
- Last updated
- 2026-03-09
Source: ClinicalTrials.gov record NCT03786900. Inclusion in this directory is not an endorsement.